Search

everythinglearnresearchcommunity

for

Search:↓

Direct patients with alopecia areata to Alopecia UK, the National Alopecia Areata Foundation, and Health Talk for the best online psychological support.

Alopecia areata in children often leads to anxiety, depression, and other mental health issues, affecting their quality of life.

Current tools inadequately measure quality of life in children with alopecia areata, needing better instruments.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Certain types of alopecia areata are linked to allergies, autoimmune diseases, and family history.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Mesenchymal Stem Cell Conditioned Media can significantly regrow hair in alopecia areata patients.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Alopecia areata significantly worsens quality of life, suggesting a need for mental health support.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Etanercept may not prevent alopecia areata from coming back.

Dupilumab may help regrow hair in people with atopic dermatitis.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

The treatment for alopecia areata with diphenylcyclopropenone was unsuccessful.

Infliximab may cause hair loss in Crohn's disease patients.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Trichoscopy helps correctly diagnose alopecia areata, not syphilitic alopecia, in patients with recent syphilis.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Ocrelizumab may cause delayed hair loss in some patients.

Secukinumab can cause hair loss, which may improve after stopping the medication.